INTRODUCTION
============

Laparoscopic cholecystectomy (LC) has gained widespread clinical acceptance as a safe and effective technique for the treatment of benign gallbladder diseases that offers rapid postoperative recovery.^[@B1][@B2][@B3]^ However, previous upper abdominal surgery has been reported as a relative contraindication to LC^[@B4],[@B5]^ because of anticipated adhesions around the abdominal wall, Calot\'s triangle, and its surrounding organs, which may increase the risk of organ injury associated with the dissection of adhesions. On the other hand, patients with previous gastrectomy have an increased incidence of cholelithiasis and increased morbidity requiring cholecystectomy.^[@B6],[@B7]^ In this retrospective study, therefore, we investigated the role of LC in the treatment of cholelithiasis and the possible risk factors that contribute to severe cholecystic morbidity requiring cholecystectomy in patients with previous gastrectomy.

MATERIALS AND METHODS
=====================

Patients and Methods
--------------------

The clinical data of 1022 patients who underwent LC in our hospital from January 1, 2010, through May 1, 2015, were reviewed retrospectively. Patients were aged between 23 and 81 years (mean, 58.0; median, 47). There were 312 men (30.5%) and 710 women (69.5%) with a male-to-female ratio of 0.439:1. No gallbladder cancer was identified. A total of 127 patients (12.4%) comprising 93 men (73.2%) and 34 women (26.8%) (male-to-female ratio 2.735:1) had undergone previous gastrectomy for gastric cancer (n = 109) and gastroduodenal ulcer (n = 18). The median interval from the time of previous surgery was 8 years (range, 2--32 years). There were 54 patients with gallstones, 12 with gallbladder polyps, and 61 with gallstones combined with gallbladder polyps. Of 41 patients with common bile duct (CBD) stones, 12 underwent endoscopic sphincterotomy (EST) to remove the stones in the preoperative period, and 29 patients underwent 1-stage laparoscopic common bile duct exploration (LCBDE) with LC. The types of previous gastrectomy were distal gastrectomy in 82 patients and total gastrectomy in 45. Analysis of variance was used to compare operation time, blood loss, conversion rate, intraoperative CBD injury rate, diet resumption, and length of postoperative hospital stay between the patients with and without a history of gastrectomy. Analysis of variance of previous gastrectomy was used to compare the severity of gallbladder disease in the postoperative period.

Surgical Procedures in Patients with a History of Gastrectomy
-------------------------------------------------------------

All patients received general anesthesia, and a standard 4-trocar technique was used. Successful insertion of the initial trocar is the first and most important step in performing LC in patients with previous gastrectomy. Using preoperative ultrasonography, we evaluate the adhesions at the original gastrectomy incision site (**[Figure 1](#F1){ref-type="fig"}A**), the distance moved by the intestine under the abdominal wall under easy breathing (**[Figure 1](#F1){ref-type="fig"}B**), and the distance from the position of insertion of the initial trocar to the superior mesenteric vein (SMV) and aorta (AO) (**[Figure 1](#F1){ref-type="fig"}C**, **D**). When the adhesions at the original gastrectomy incision site are severe, we prefer to choose the site just right of the umbilicus, 3 cm from the original gastrectomy incision. When preoperative ultrasonography shows lateral movement of the intestine of less than 1 cm and longitudinal movement of less than 3 cm under easy breathing, we anticipate that the adhesions are severe,^[@B8]^ so safe peritoneal access (i.e., open the peritoneum under direct vision through a small incision) is applied to these patients. When organs such as the duodenum, small intestine, or colon adhere to the gallbladder or Calot\'s triangle, a safe dissection technique, such as dissecting the serosa of the gallbladder to prevent injury to these organs or using suction to push and suck to separate the adhesions around the Calot triangle, is performed. Because of translocation of the CBD resulting from adhesions after gastrectomy, we divided the cystic duct until the common hepatic duct and CBD were clearly identified.

###### 

Ultrasonograms. **A,** Evaluation of adhesions at the original gastrectomy incision site by preoperative ultrasonography. **B,** Movement distance of intestine (IN) under the abdominal wall under easy breathing. **C, D,** Distance from the position of insertion of the initial trocar to the superior mesenteric vein (SMV) and aorta (AO).
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Statistical Analysis
--------------------

All statistical analyses were conducted with SPSS software (version 19.0 for Windows; IBM, Armonk, New York, USA). Continuous variables were summarized by calculating means and standard deviations, whereas frequencies and percentages were used for categorical variables. Student\'s *t* test and Fisher\'s exact test were used for quantitative data. Pearson\'s correlation test was used for correlation analysis. Values of *P*\< 0.05 were considered to be statistically significant.

RESULTS
=======

Patients\' Characteristics
--------------------------

The mean age and the incidence of CBD stones were higher in patients with a history of gastrectomy (*P* \< .05), and previous gastrectomy was more common in men, as shown in **[Table 1](#T1){ref-type="table"}**.

###### 

Patient Characteristics

  Characteristic                    No Gastrectomy History (n = 895)   Gastrectomy History (n = 127)   *P*
  --------------------------------- ---------------------------------- ------------------------------- -------
  Age (years) (mean ± SD)           50.23 ± 10.2                       68.45 ± 9.5                     \<.05
  Male, n (%)                       312 (30.5)                         93 (73.2)                       \<.05
  Combined with CBD stones, n (%)   116 (11.7)                         41 (32.3)                       \<.05

CBD, common bile duct.

Operative Details
-----------------

Adhesions to the gallbladder were found in all patients with a history of gastrectomy, but adhesions to the abdominal wall were found in only 32 (25.2%) patients. Patients with an interval between gastrectomy and LC of more than 5 years had a lower incidence of adhesions to the abdominal wall (*P* \< .05). Organs adhering to the gallbladder included the greater omentum (52, 40.9%), duodenum (47, 37.0%), colon (18, 14.2%), and small intestine (10, 7.9%), as shown in **[Table 2](#T2){ref-type="table"}**.

###### 

Adhesion Characteristics of the Patients With a History of Gastrectomy

  Characteristic, n (%)                               Data
  --------------------------------------------------- --------------------------------------------
  Adhesions to the abdominal wall (n = 32)            
      Interval between gastrectomy and LC \<5 years   27 (84.4)[\*](#TF2-1){ref-type="table-fn"}
      Interval between gastrectomy and LC \>5 years   5 (15.6)
  Organs adhering to gallbladder (n = 127)            
      Greater omentum                                 52 (40.9)
      Duodenum                                        47 (37.0)
      Colon                                           18 (14.2)
      Small intestine                                 10 (7.9)

LC, laparoscopic cholecystectomy.

*P* \< .05.

Details of Gallbladder Disease in Patients with a History of Gastrectomy
------------------------------------------------------------------------

The frequency of cholecystitis attacks and the rates of combination with gallbladder polyp and pancreatitis, were higher, and gallstone formation time shorter, in patients with malignant tumor, those who had undergone Billroth II gastroenterostomy or esophagojejunostomy, and those with accompanying diabetes mellitus or hypercholesterolemia (*P* \< .05). There was no significant difference in age and sex (**[Table 3](#T3){ref-type="table"}**).

###### 

Details of Gallbladder Disease in Patients With History of Gastrectomy

  Patient Characteristics                 Cholecystitis Episode Frequency (per Month) (Mean ± SD)   Gallstone Formation Time (Months) (Mean ± SD)   Gallbladder Polyp Combination Rate, n (%) (61/127)   Pancreatitis Combination Rate, n (%) (45/127)
  --------------------------------------- --------------------------------------------------------- ----------------------------------------------- ---------------------------------------------------- -----------------------------------------------
  Sex                                                                                                                                                                                                    
      Male (n = 93)                       2.33 ± 1.5                                                7.34 ± 5.2                                      45 (48.3)                                            32 (34.4)
      Female (n = 34)                     2.57 ± 2.1                                                8.01 ± 4.3                                      16 (47.1)                                            13 (38.2)
  Age (years)                                                                                                                                                                                            
      \<65 (n = 32)                       2.58 ± 2.9                                                8.15 ± 4.7                                      18 (56.3)                                            12 (37.5)
      ≥65 (n = 95)                        2.21 ± 1.7                                                7.03 ± 4.9                                      43 (45.3)                                            33 (34.7)
  Method of reconstruction                                                                                                                                                                               
      Billroth I (n = 38)                 0.97 ± 4.9                                                10.91 ± 3.7                                     4 (10.5)                                             3 (7.9)
      Billroth II or Roux-en-Y (n = 99)   3.73 ± 2.5[\*](#TF3-1){ref-type="table-fn"}               4.22 ± 2.9[\*](#TF3-1){ref-type="table-fn"}     57 (57.6)[\*](#TF3-1){ref-type="table-fn"}           42 (42.4)[\*](#TF3-1){ref-type="table-fn"}
  Pathology of disease                                                                                                                                                                                   
      Benign (n = 18)                     1.01 ± 3.6                                                12.15 ± 3.5                                     2 (11.1)                                             1 (5.5)
      Malignant (n = 109)                 3.77 ± 4.4[\*](#TF3-1){ref-type="table-fn"}               3.04 ± 1.4[\*](#TF3-1){ref-type="table-fn"}     59 (54.1)                                            44 (40.4)[\*](#TF3-1){ref-type="table-fn"}
  Diabetes mellitus                                                                                                                                                                                      
      Yes (n = 80)                        4.26 ± 1.2                                                3.33 ± 1.7                                      55 (68.8)                                            43 (53.8)
      No (n = 47)                         0.52 ± 3.4[\*](#TF3-1){ref-type="table-fn"}               11.76 ± 4.2[\*](#TF3-1){ref-type="table-fn"}    6 (12.8)[\*](#TF3-1){ref-type="table-fn"}            2 (4.3)[\*](#TF3-1){ref-type="table-fn"}
  Hypercholesterolemia                                                                                                                                                                                   
      Yes (n = 78)                        3.34 ± 2.6                                                4.11 ± 2.1                                      54 (69.2)                                            40 (51.3)
      No (n = 49)                         1.24 ± 3.2[\*](#TF3-1){ref-type="table-fn"}               10.55 ± 2.2[\*](#TF3-1){ref-type="table-fn"}    7 (14.3)[\*](#TF3-1){ref-type="table-fn"}            5 (10.2)[\*](#TF3-1){ref-type="table-fn"}

*P* \< .05.

Clinical Outcomes
-----------------

The average operative time in patients with pervious gastrectomy was longer (*P* \< .05), as shown in **[Table 4](#T4){ref-type="table"}**. The operative time for patients with a long interval (\>5 y) between gastrectomy and LC showed no statistically significant difference from that for patients without a gastrectomy history (*P* \> .05), but was significantly shorter than that for patients whose interval was less than 5 years (*P* \< .05), as shown in **[Table 5](#T5){ref-type="table"}**. There were no significant differences between the two groups with regard to blood loss, conversion rate, intraoperative CBD injury rate, diet resumption, and postoperative hospital stay (*P* \> .05) (**[Table 4](#T4){ref-type="table"}).** The conversion rate during the early period of performing LC in patients with previous gastrectomy was higher than that during the later period (*P* \< .05), as shown in **[Table 6](#T6){ref-type="table"}**.

###### 

Operative Details and Clinical Outcomes

  Operative Details                             No Gastrectomy History (n = 895)   Gastrectomy History (n = 127)   *P*
  --------------------------------------------- ---------------------------------- ------------------------------- -------
  Operation time (min)                          51.4 ± 22.7                        84.6 ± 20.5                     \<.05
  Blood loss (mL)                               25.4 ± 6.4                         27.3 ± 7.5                      \>.05
  Conversion rate, n (%)                        28 (3.1)                           6 (4.7)                         \>.05
  Intraoperative bile duct injury rate, n (%)   12 (1.3)                           2 (1.6)                         \>.05
  Diet resumption (days)                        1.1 ± 0.5                          1.2 ± 0.6                       \>.05
  Postoperative hospital stay (days)            3.2 ± 2.2                          3.4 ± 1.9                       \>.05

Data are the mean ± SD unless otherwise noted.

###### 

Operation Times for Different Intervals

                         Interval Between Gastrectomy and LC \<5 Years (n = 80)   Interval Between Gastrectomy and LC \>5 Years (n = 47)   No Gastrectomy History (n = 895)
  ---------------------- -------------------------------------------------------- -------------------------------------------------------- -----------------------------------------------
  Operation time (min)   89.6 ± 25.7                                              61.3 ± 21.2[\*](#TF5-1){ref-type="table-fn"}             51.4 ± 22.7^[†](#TF5-2){ref-type="table-fn"}^

*P* \< .05: patients with interval of more than 5 years between 2 operations, whose operation time was less than the patients whose interval was less than 5 years.

*P* \> .05: patients with interval of more than 5 years between 2 operations, whose operation time is not different from that of patients without previous gastrectomy.

###### 

Conversion Rate During Different Periods of Administering LC in Patients With Previous Gastrectomy

  Rate                  Early period (2010.1--2011.11)   Later period (2011.12--2015.5)   *P*
  --------------------- -------------------------------- -------------------------------- -------
  Conversion rate (%)   19.2 (5/26)                      1.0 (1/101)                      \<.05

DISCUSSION
==========

It is widely accepted that the incidence of gallstone formation after gastrectomy is higher than that in the population without surgical history, ranging from 13 to 22%.^[@B9]^ Mechanisms for these observations remain unclear. According to the literature, when a patient undergoes gastrectomy, damage to the hepatic branch of the vagus nerve and gastric reconstruction that reduces the passage of food through the duodenum are unavoidable, leading to abnormal secretion of cholecystokinin and a probable decrease in gallbladder motility, and, ultimately, gallstone formation.^[@B10][@B11][@B13]^

Previous upper abdominal surgery, especially gastrectomy, has been considered a relative contraindication for LC. Laparoscopic surgery failures in patients with previous gastrectomy were attributable to adhesions, such as around the position of initial trocar insertion and in proximity to the gallbladder and CBD.^[@B14]^ These adhesions harbor the risk of injury to the adhesive organs and lead to the necessity for open surgery. According to the literature, the conversion rate of LC in patients with previous gastrectomy ranged from 7.7 to 50%.^[@B15]^ In our series, we encountered a low conversion rate of 4.7%. During the early period of performing LC in patients with a history of gastrectomy, the operation in 1 patient in our series was converted to open surgery because, at the preoperative evaluation, we lost the information concerning the anastomotic leakage that occurred during the previous operation. As in such patients adhesions in the abdomen can be very severe and dense, insertion of the initial trocar failed and injured the colon, forcing us to perform open surgery. After this case, we adopted a preoperative evaluation procedure that anticipates the severity level of the intra-abdominal adhesions by assessing factors including hyperplasia of the original incision, postoperative intestinal obstruction, method of gastroenterostomy, abdominal infection,^[@B4]^ and preoperative ultrasonography. Throughout the procedure, we obtained a score to anticipate the severity level of the intra-abdominal adhesions, as shown in **[Table 7](#T7){ref-type="table"}**. When the score was more than 3 points, extensive intra-abdominal adhesions were suspected, and safe peritoneal access (i.e., the peritoneum is opened under direct vision through a small incision) was recommended.^[@B16]^ As the technique of safe peritoneal access is not difficult, comprehensive and accurate preoperative evaluation of adhesion severity confers an important benefit in reducing the conversion rate. After we adopted this preoperative evaluation procedure the conversion rate decreased, as shown in **[Table 6](#T6){ref-type="table"}**. With respect to dealing with adhesions around the gallbladder, we suggest dissecting the serosa of the gallbladder to prevent injury to the adhering organs.^[@B17]^ Our method consists in using an electrocoagulation hook to dissect the adhesion line, followed by the use of suction to push and suck and thus separate the adhesions around Calot\'s triangle, which helps to avoid injuring the bile duct.

###### 

Preoperative Evaluation to Anticipate Severity Level of Intra-abdominal Adhesions

  Evaluation                             Score (points)               
  -------------------------------------- ---------------------------- ------------------------------
  Hyperplasia of original incision       No (0)                       Yes (1)
  Postoperative intestinal obstruction   No (0)                       Yes (1)
  Abdominal infection                    No (0)                       Yes (1)
  Methods of gastroenterostomy           Billroth I (0)               Billroth II or Roux-en-Y (1)
  Preoperative ultrasonography test      Lateral MD \>1 cm (0)        Lateral MD \<1 cm (2)
                                         Longitudinal MD \>3 cm (0)   Longitudinal MD \<3 cm (2)

MD, movement distance.

In the present, study we found that the average operative time in patients with a history of gastrectomy was longer, but also that patients with a long interval between gastrectomy and LC have an operation time similar to that of those without surgical history and less than that for those with a short interval; moreover, the incidence of adhesions to the abdominal wall was lower among patients with a long interval between operations. In other words, a longer interval between operations is related to fewer intra-abdominal adhesions and a more efficient LC procedure. Therefore, our first option for patients requiring treatment of cholecystic morbidity more than 5 years after initial surgery would be LC. We also found that frequency of cholecystitis attacks and rates of combination with gallbladder polyp and pancreatitis were higher, whereas gallstone formation time was shorter in patients with malignant tumor, those who had undergone Billroth II gastroenterostomy or esophagojejunostomy, and those with accompanying diabetes mellitus or hypercholesterolemia. These results suggest the initiation of aggressive treatment of cholecystic morbidity during the postgastrectomy period in patients with the aforementioned risk factors. We also observed no significant differences between our 2 groups with regard to conversion rate and intraoperative and postoperative outcomes, demonstrating that LC is a viable therapeutic choice for the treatment of gallbladder disease in patients with a history of gastrectomy, although comprehensive preoperative evaluation and the skill of the surgeon are necessary requirements for efficacious results.
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